Relative Strength Chart Genmab A/S Nasdaq

Stocks

Delayed Nasdaq Other stock markets 22:53:33 15/06/2026 +03			5-day change	1st Jan Change
24.57 ^USD	-2.03%		-0.95%	-20.24%

07:57am	Nordic Equities in North America: Ericsson Slides 1.4 Percent	FW
06-13	Genmab Announces Epcoritamab Monotherapy And Epcoritamab-Based Combination Regimens Demonstrate High Response Rates In Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	GENMAB A/S	Bio Therapeutic Drugs	-2.03%	-0.95%	-20.24%	+7.46%	-44.20%	15.4B	-	-	-